[Immunopathogenesis of different forms of glomerulonephritis. Possible indications for immunosuppressive therapy].
D000208:Acute Disease; D000818:Animals; D019867:Anti-Glomerular Basement Membrane Disease / Q000276:immunology; D000936:Antigen-Antibody Complex / Q000009:adverse effects; D001327:Autoimmune Diseases / Q000209:etiology; D002648:Child; D002908:Chronic Disease; D005260:Female; D005921:Glomerulonephritis / Q000145:classification / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D006168:Guinea Pigs; D006417:Hematuria / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008179:Lupus Erythematosus, Discoid / Q000473:pathology; D051379:Mice; D009393:Nephritis / Q000150:complications / Q000276:immunology / Q000473:pathology; D009402:Nephrosis, Lipoid / Q000276:immunology; D011247:Pregnancy; D011248:Pregnancy Complications; D011704:Pyelonephritis / Q000276:immunology; D011817:Rabbits; D051381:Rats; D012713:Serum Sickness / Q000150:complications; D012756:Sheep
D000936:Antigen-Antibody Complex; D007166:Immunosuppressive Agents
Immunpathogenese verschiedener Formen der Glomerulonephritis. Mögliche Ansatzpunkte für eine immunsuppressive Therapie.